E., Redon J., Richter D. J., Sattar N., Smulders Y., Tiberi M., Worp V. D., Bart H., Dis I van, Verschuren W. M. M., Binno S., De Backer G., Roffi M., et al. 2016 European Guidelines on cardiovascular disease prevention in clinical practice The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts) Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR).
Eur Heart J 2016; 37:2315–2381.
36
Ravnskov U., Diamond D. M., Hama R., Hamazaki T., Hammarskjöld B., Hynes N., Kendrick M., Langsjoen P. H., Malhotra A., Mascitelli L., McCully K. S., Ogushi Y., Okuyama H., Rosch P. J., Schersten T., Sultan S., Sundberg R. Lack of an association or an inverse association between low-density-lipoprotein cholesterol and mortality in the elderly: a systematic review. BMJ Open 2016; 6:e010401.
37
Group SSSS. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). The Lancet 1994; 344:1383–1389.
38
Sabatine M. S., Giugliano R. P., Keech A. C., Honarpour N., Wiviott S. D., Murphy S. A., Kuder J. F., Wang H., Liu T., Wasserman S. M., Sever P. S., Pedersen T. R. Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease. N Engl J Med 2017; 376:1713–1722.
39
Evaluation of Cardiovascular Outcomes After an Acute Coronary Syndrome During Treatment With Alirocumab. Am. Coll. Cardiol. http%3a%2f%2fwww.acc.org%2flatest-incardiology%2fclinical-trials%2f2018%2f03%2f09%2f08%2f02%2fodyssey-outcomes (30 June 2018).
40
Cebelin M. S., Hirsch C. S. Human stress cardiomyopathy: Myocardial lesions in victims of homicidal assaults without internal injuries. Hum Pathol 1980; 11:123–132.
41
Отчасти потому, что от этого крошечные кровеносные сосуды внутренней части миокарда сжимаются и кровоток останавливается, а отчасти потому, что это воздействует непосредственно на клетки сердца.
42
Steptoe A., Kivimäki M. Stress and cardiovascular disease. Nat Rev Cardiol 2012; 9:360–370.
43
Kivimäki M., Virtanen M., Elovainio M., Kouvonen A., Väänänen A., Vahtera J. Work stress in the etiology of coronary heart disease – a meta-analysis. Scand J Work Environ Health 2006; 32:431–442.
44
Virtanen M., Heikkilä K., Jokela M., Ferrie J. E., Batty G. D., Vahtera J., Kivimäki M. Long Working Hours and Coronary Heart Disease: A Systematic Review and Meta-Analysis. Am J Epidemiol 2012; 176:586–596.
45
Kaplan J. R., Manuck S. B., Clarkson T. B., Lusso F. M., Taub D. M., Miller E. W. Social stress and atherosclerosis in normocholesterolemic monkeys. Science 1983; 220:733–735.
46
Brunner E. J., Marmot M. G., Nanchahal K., Shipley M. J., Stansfeld S. A., Juneja M., Alberti K. G. M. M. Social inequality in coronary risk: Central obesity and the metabolic syndrome. Evidence from the Whitehall II study. Diabetologia 1997; 40:1341–1349.
47
Steptoe A., Kivimäki M. Stress and cardiovascular disease: an update on current knowledge. Annu Rev Public Health 2013; 34:337–354.
48
Fang F., Fall K., Mittleman M. A., Sparén P., Ye W., Adami H.-O., Valdimarsdóttir U. Suicide and Cardiovascular Death after a Cancer Diagnosis. N Engl J Med 2012; 366:1310–1318.
49
Meijer A., Conradi H. J., Bos E. H., Thombs B. D., Melle J. P. van, Jonge P. de. Prognostic association of depression following myocardial infarction with mortality and cardiovascular events: a meta-analysis of 25 years of research. Gen Hosp Psychiatry 2011; 33:203–216.
50
Arnold S. V., Smolderen K. G., Buchanan D. M., Li Y., Spertus J. A. Perceived Stress in Myocardial Infarction: Long-Term Mortality and Health Status Outcomes. J Am Coll Cardiol 2012; 60:1756–1763.
51
Knott C. S., Coombs N., Stamatakis E., Biddulph J. P. All cause mortality and the case for age specific alcohol consumption guidelines: pooled analyses of up to 10 population based cohorts. BMJ 2015; 350:h384.
52
Semba R. D., Ferrucci L., Bartali B., Urpí-Sarda M., Zamora-Ros R., Sun K., Cherubini A., Bandinelli S., Andres-Lacueva C. Resveratrol levels and all-cause mortality in older community-dwelling adults. JAMA Intern Med 2014; 174:1077–1084.
53
Knott C. S., Coombs N., Stamatakis E., Biddulph J. P. All cause mortality and the case for age specific alcohol consumption guidelines: pooled analyses of up to 10 population based cohorts. BMJ 2015; 350:h384.
54
Wood A. M., Kaptoge S., Butterworth A. S., Willeit P., Warnakula S., Bolton T., Paige E., Paul D. S., Sweeting M., Burgess S., Bell S., Astle W., Stevens D., Koulman A., Selmer R. M., Verschuren W. M. M., Sato S., Njølstad I., Woodward M., Salomaa V., Nordestgaard B. G., Yeap B. B., Fletcher A., Melander O., Kuller L. H., Balkau B., Marmot M., Koenig W., Casiglia E., Cooper C., et al. Risk thresholds for alcohol consumption: combined analysis of individual-participant data for 599 912 current drinkers in 83 prospective studies. The Lancet 2018; 391:1513–1523.
55
DeBusk R. F. Sexual Activity in Patients With Angina. JAMA 2003; 290:3129–3132.
56
Dahabreh I. J., Paulus J. K. Association of Episodic Physical and Sexual Activity With Triggering of Acute Cardiac Events: Systematic Review and Meta-analysis. JAMA 2011; 305:1225–1233.
57
Levine G. N., Steinke E. E., Bakaeen F. G., Bozkurt B., Cheitlin M. D., Conti J. B., Foster E., Jaarsma T., Kloner R. A., Lange R. A., Lindau S. T., Maron B. J., Moser D. K., Ohman E. M., Seftel A. D., Stewart W. J. Sexual Activity and Cardiovascular Disease: A Scientific Statement From the American Heart Association. Circulation 2012; 125:1058–1072.
58
Möller J., Ahlbom A., Hulting J., Diderichsen F., Faire
